Microglia and inflammation in Alzheimer’s disease
Lei De-liang
Abstract
Lei De-liang
Abstract
Accumulating data evidenced inflammation involved in Alzheimer’s disease (AD). Microglia, one of the main immune cells in central nerve system, was activated in inflammation with morphological changes from resting ramified to staffed and amoeboid cells. Moreover, toxic cytokines and inflammatory mediators were released, which exerted a series of influence on adjacent tissue. Inhibiting the microglia activation to attenuate inflammatory damage will be an important strategy to prevent the further deterioration in AD.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Accumulating data evidenced inflammation involved in Alzheimer’s disease (AD). Microglia, one of the main immune cells in central nerve system, was activated in inflammation with morphological changes from resting ramified to staffed and amoeboid cells. Moreover, toxic cytokines and inflammatory mediators were released, which exerted a series of influence on adjacent tissue. Inhibiting the microglia activation to attenuate inflammatory damage will be an important strategy to prevent the further deterioration in AD.
Key concepts: Microglia, Inflammation, Immune system, Neuroinflammation, Alzheimer's disease, Neuroscience, Disease, Immunology